Combination Therapy with Indolylquinoline Derivative and Sodium Antimony Gluconate Cures Established Visceral Leishmaniasis in Hamsters

Pal, Chiranjib ; Raha, Mousumi ; Basu, Anirban ; Roy, Keshab Chandra ; Gupta, Anasuya ; Ghosh, Monidipa ; Sahu, Niranjan Prasad ; Banerjee, Sukdeb ; Mandal, Nirup Bikash ; Bandyopadhyay, Santu (2002) Combination Therapy with Indolylquinoline Derivative and Sodium Antimony Gluconate Cures Established Visceral Leishmaniasis in Hamsters Antimicrobial Agents and Chemotherapy, 46 (1). pp. 259-261. ISSN 0066-4804

Full text not available from this repository.

Official URL: http://doi.org/10.1128/AAC.46.1.259-261.2002

Related URL: http://dx.doi.org/10.1128/AAC.46.1.259-261.2002

Abstract

2-(2″-Dichloroacetamidobenzyl)-3-(3′-indolylquinoline), designated indolylquinoline derivative A, reduced the splenic and the liver parasite burdens by >93.0% in Leishmania donovani-infected hamsters, whereas sodium antimony gluconate (SAG) reduced the burdens approximately 80.0%. Complete clearance of parasitemia from the livers and spleens was noticed when infected animals received indolylquinoline derivative A plus SAG, suggesting that indolylquinoline derivative A has potential as a new agent for sole or conjunctive therapy for leishmaniasis.

Item Type:Article
Source:Copyright of this article belongs to American Society for Microbiology.
Keywords:Antimony Sodium Gluconate; Antiprotozoal Agents; Indoles; Leishmaniasis Visceral; Quinolines.
ID Code:115691
Deposited On:18 Mar 2021 04:52
Last Modified:18 Mar 2021 04:52

Repository Staff Only: item control page